Closure of trading window for the quarter ending December 31,2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kimia Biosciences Ltd has informed the stock exchange that its trading window for dealing in company securities will be closed for all designated persons and their immediate relatives starting January 1, 2026. The window will remain shut until 48 hours after the company declares its unaudited financial results for the quarter ending December 31, 2025. This is a standard compliance measure under SEBI's Insider Trading Regulations, 2015, and the company's internal code of conduct. The board meeting date to approve the Q3 results will be announced separately in due course.
This is a routine regulatory disclosure and does not have a direct impact on shareholders or the stock price. It simply restricts designated employees and insiders from trading in the company's shares until the quarterly results are made public, ensuring fair disclosure.